These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

911 related items for PubMed ID: 30738132

  • 1. Development of morin/hydroxypropyl-β-cyclodextrin inclusion complex: Enhancement of bioavailability, antihyperalgesic and anti-inflammatory effects.
    Lima BDS, Campos CA, da Silva Santos ACR, Santos VCN, Trindade GDGG, Shanmugam S, Pereira EWM, Marreto RN, Duarte MC, Almeida JRGDS, Quintans JSS, Quintans LJ, Araújo AAS.
    Food Chem Toxicol; 2019 Apr; 126():15-24. PubMed ID: 30738132
    [Abstract] [Full Text] [Related]

  • 2. Preparation of curcumin-hydroxypropyl-β-cyclodextrin inclusion complex by cosolvency-lyophilization procedure to enhance oral bioavailability of the drug.
    Li N, Wang N, Wu T, Qiu C, Wang X, Jiang S, Zhang Z, Liu T, Wei C, Wang T.
    Drug Dev Ind Pharm; 2018 Dec; 44(12):1966-1974. PubMed ID: 30059244
    [Abstract] [Full Text] [Related]

  • 3. Anti-hyperalgesic and anti-inflammatory effects of citral with β-cyclodextrin and hydroxypropyl-β-cyclodextrin inclusion complexes in animal models.
    Campos CA, Lima BS, Trindade GGG, Souza EPBSS, Mota DSA, Heimfarth L, Quintans JSS, Quintans-Júnior LJ, Sussuchi EM, Sarmento VHV, Carvalho FMS, Marreto RN, Costa RMR, Nunes RS, Araújo AAS, Shanmugam S, Thangaraj P.
    Life Sci; 2019 Jul 15; 229():139-148. PubMed ID: 31085246
    [Abstract] [Full Text] [Related]

  • 4. Preparation, characterization and in vivo evaluation of formulation of repaglinide with hydroxypropyl-β-cyclodextrin.
    Liu M, Cao W, Sun Y, He Z.
    Int J Pharm; 2014 Dec 30; 477(1-2):159-66. PubMed ID: 25455768
    [Abstract] [Full Text] [Related]

  • 5. Preparation and characterisation of ecdysterone/hydroxypropyl-Β-cyclodextrin inclusion complex with enhanced oral and transdermal bioavailability.
    Wang L, Li S, Cai H, Liu X, Feng T, Zhao X.
    J Microencapsul; 2022 Mar 30; 39(2):145-155. PubMed ID: 35311602
    [Abstract] [Full Text] [Related]

  • 6. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
    Jun SW, Kim MS, Kim JS, Park HJ, Lee S, Woo JS, Hwang SJ.
    Eur J Pharm Biopharm; 2007 Jun 30; 66(3):413-21. PubMed ID: 17240129
    [Abstract] [Full Text] [Related]

  • 7. Solubility Enhancement of Myricetin by Inclusion Complexation with Heptakis-O-(2-Hydroxypropyl)-β-Cyclodextrin: A Joint Experimental and Theoretical Study.
    Han D, Han Z, Liu L, Wang Y, Xin S, Zhang H, Yu Z.
    Int J Mol Sci; 2020 Jan 24; 21(3):. PubMed ID: 31991574
    [Abstract] [Full Text] [Related]

  • 8. Inclusion Complexation of Etodolac with Hydroxypropyl-beta-cyclodextrin and Auxiliary Agents: Formulation Characterization and Molecular Modeling Studies.
    Sherje AP, Kulkarni V, Murahari M, Nayak UY, Bhat P, Suvarna V, Dravyakar B.
    Mol Pharm; 2017 Apr 03; 14(4):1231-1242. PubMed ID: 28248111
    [Abstract] [Full Text] [Related]

  • 9. Enhancement of the solubility and oral bioavailability of altrenogest through complexation with hydroxypropyl-β-cyclodextrin.
    Chen W, Zheng X, Lao W, Wang H, Chen S, Liu C, Chen Z, Bai Y, Zhang H, Zhan X, Wang B.
    Eur J Pharm Sci; 2024 Mar 01; 194():106691. PubMed ID: 38181869
    [Abstract] [Full Text] [Related]

  • 10. Elucidation of the orientation of selected drugs with 2-hydroxylpropyl-β-cyclodextrin using 2D-NMR spectroscopy and molecular modeling.
    Adhikari S, Daftardar S, Fratev F, Rivera M, Sirimulla S, Alexander K, Boddu SHS.
    Int J Pharm; 2018 Jul 10; 545(1-2):357-365. PubMed ID: 29747001
    [Abstract] [Full Text] [Related]

  • 11. Preparation, characterization and in vivo evaluation of a formulation of dantrolene sodium with hydroxypropyl-β-cyclodextrin.
    Chen M, Wu Q, Jiang J, Jin X, Liu S, Wang M, Zhao C.
    J Pharm Biomed Anal; 2017 Feb 20; 135():153-159. PubMed ID: 28027523
    [Abstract] [Full Text] [Related]

  • 12. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM, Elkheshen SA, Ghorab MM.
    Eur J Pharm Biopharm; 2008 Nov 20; 70(3):819-27. PubMed ID: 18655829
    [Abstract] [Full Text] [Related]

  • 13. In vitro and in vivo studies on the complexes of vinpocetine with hydroxypropyl-beta-cyclodextrin.
    Nie S, Fan X, Peng Y, Yang X, Wang C, Pan W.
    Arch Pharm Res; 2007 Aug 20; 30(8):991-1001. PubMed ID: 17879753
    [Abstract] [Full Text] [Related]

  • 14. Inclusion Complexes of Hydroxy Propyl-β-Cyclodextrin and Paliperidone: Preparation and Characterization.
    Sherje A, Londhe V.
    Curr Drug Discov Technol; 2014 Aug 20; 11(4):271-8. PubMed ID: 25578059
    [Abstract] [Full Text] [Related]

  • 15. Complexation of oxethazaine with 2-hydroxypropyl-β-cyclodextrin: increased drug solubility, decreased cytotoxicity and analgesia at inflamed tissues.
    Prado AR, Yokaichiya F, Franco MKKD, Silva CMGD, Oliveira-Nascimento L, Franz-Montan M, Volpato MC, Cabeça LF, de Paula E.
    J Pharm Pharmacol; 2017 Jun 20; 69(6):652-662. PubMed ID: 28211640
    [Abstract] [Full Text] [Related]

  • 16. Liquiritin-Hydroxypropyl-Beta-Cyclodextrin Inclusion Complex: Preparation, Characterization, Bioavailability and Antitumor Activity Evaluation.
    Wang Q, Zhang K, Weng W, Chen L, Wei C, Bao R, Adu-Frimpong M, Cao X, Yu Q, Shi F, Toreniyazov E, Ji H, Xu X, Yu J.
    J Pharm Sci; 2022 Jul 20; 111(7):2083-2092. PubMed ID: 35367247
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Nanosuspensions Containing Oridonin/HP-β-Cyclodextrin Inclusion Complexes for Oral Bioavailability Enhancement via Improved Dissolution and Permeability.
    Zhang X, Zhang T, Lan Y, Wu B, Shi Z.
    AAPS PharmSciTech; 2016 Apr 20; 17(2):400-8. PubMed ID: 26187778
    [Abstract] [Full Text] [Related]

  • 19. Inclusion complex of ITH12674 with 2-hydroxypropyl-β-cyclodextrin: Preparation, physical characterization and pharmacological effect.
    Michalska P, Wojnicz A, Ruiz-Nuño A, Abril S, Buendia I, León R.
    Carbohydr Polym; 2017 Feb 10; 157():94-104. PubMed ID: 27988012
    [Abstract] [Full Text] [Related]

  • 20. Inclusion complexes of tea polyphenols with HP-β-cyclodextrin:Preparation, characterization, molecular docking, and antioxidant activity.
    Zhong Y, Li W, Ran L, Hou R, Han P, Lu S, Wang Q, Zhao W, Zhu Y, Dong J.
    J Food Sci; 2020 Apr 10; 85(4):1105-1113. PubMed ID: 32175596
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.